Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38821b2e65ea28d17d085883fefeacdd |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-708 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2010-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c8d3368328b4e3ca9e7a17f51789e4d |
publicationDate |
2010-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2010131020-A |
titleOfInvention |
Method for detecting human papillomavirus mRNA |
abstract |
An in vitro method for screening human female subjects to assess their risk of developing cervical cancer. A subject who is positive for L1 mRNA and / or E6 mRNA expression develops cervical cancer, comprising screening the subject for expression of mRNA transcripts derived from the human papillomavirus E6 gene and optionally the L1 gene It is evaluated as having a risk of Kit for carrying out such a method. [Selection figure] None |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014501535-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10812763-B2 |
priorityDate |
2002-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |